Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia

Diseases of the Esophagus

Volumn 21, Issue 6, 2008, Pages 488-495

  Buskens, C J ^a   Ten Kate, F J W ^b   Obertop, H ^a   Izbicki, J R ^c   van Lanschot, J J B ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Esophageal cancer; Immunohistochemistry; Lymph node; Micrometastasis

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; MONOCLONAL ANTIBODY CAM 5.2;

ADULT; AGED; ARTICLE; CANCER STAGING; CARDIA CARCINOMA; CLINICAL ARTICLE; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MICROMETASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; THORAX SURGERY;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THORACOTOMY; TREATMENT OUTCOME;

EID: 51249105310     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00805.x     Document Type: Article

References (34)

1. Enzinger P C, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
2. Daly J M, Fry W A, Little A G et al. Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 2000; 190: 562-72.
3. Roder J D, Busch R, Stein H J, Fink U, Siewert J R. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-3.
4. Hulscher J B, Van Sandick J W, Offerhaus G J, Tilanus H W, Obertop H, Van Lanschot J J. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg 2001; 88: 715-19.
5. Hulscher J B F, Tijssen J G P, Obertop H, Van Lanschot J J B. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
6. Hulscher J B, Van Sandick J W, De Boer A G et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
7. Singletary S E, Greene F L, Sobin L H. Classification of isolated tumor cells: Clarification of the 6th edition of the American Joint Committee on Cancer Staging manual. Cancer 2003; 98: 2740-1.
8. Sobin L H, Wittekind C, (eds). UICC TNM Classification of Malignant Tumours, 6th edn. New York: John Wiley & Sons, Inc., 2002.
9. Izbicki J R, Hosch S B, Pichlmeier U et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337: 1188-94.
10. Natsugoe S, Mueller J, Stein H J, Feith M, Hofler H, Siewert J R. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998; 83: 858-66.
11. Glickman J N, Torres C, Wang H H et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999; 85: 769-78.
12. Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001; 88: 426-32.
13. Mueller JD, Stein HJ, Oyang T et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinom of the esophagogastric junction. Cancer 2000; 89: 1874-82.
14. Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol 2002; 79: 224-9.
15. Komukai S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 2002; 89: 213-29.
16. Schurr P G, Yekebas E F, Kair J T et al. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction. J Surg Oncol 2006; 94: 307-15.
17. Wijnhoven B L, Siersema P D, Hop W C J, Van Dekken H, Tilanus H W. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Br J Surg 1999; 86: 529-35.
18. Latza U, Niedobitek G, Schwarting R, Nekarda N, Stein H. Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990; 43: 213-19.
19. Momburg F, Moldenhauer G, Hammerling G J, Moller P. Immunohistochemical study of the expression of a Mr 34 000 human epithelium-specific surface glycoprotein in normal an malignant tissues. Cancer Res 1987; 47: 2883-91.
20. Woodcock-Mitchell J, Eichner R, Nelson W G, Sun T T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982; 95: 580-8.
21. Hermanek P, Hutter R V P, Sobin L H, Wittekind C. Classification of isolated tumour cells and micrometastasis. Cancer 1999; 86: 2668-73.
22. Thorban S, Roder J D, Nekarda H, Funk A, Pantel K, Siewert J R. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: Detection and prognostic significance. World J Surg 1996; 20: 567-73.
23. Macadam R, Sarela A, Wilson J, MacLennan K, Guillou P. Bone Marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol 2003; 29: 450-4.
24. Nishimaki T, Suzuki T, Kanda T, Obinata I, Komukai S, Hatakeyama K. Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery 1999; 125: 142-7.
25. Wong J H, Severino R, Honnebier M B, Tom P, Namiki T S. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999; 17: 2896-900.
26. O'Sullivan G C, Sheehan D, Clarke A et al. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments. Gastroenterology 1999; 116: 543-8.
27. Gebauer G, Fehm T, Merkle E, Beck E P, Lang N, Jager W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol 2001; 19: 3669-74.
28. Abati A, Liotta L A. Looking forward in diagnostic patho-logy. The molecular superhighway. Cancer 1996; 78: 1-3.
29. Czerniecki B J, Scheff A M, Callans L S et al. Immunohistochemistry with pancytokeratins improve the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999; 85: 1098-103.
30. Cense H A, van Eijk C H, Tilanus H W. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol 2006; 20: 893-906.
31. Burian M, Stein H J, Sendler A et al. Sentinel node detection in Barrett's and cardia cencer. Ann Surg Oncol 2004; 11: 255S-8S.
32. Lamb P J, Griffin S M, Burt A D, Lloyed J, Karat D, Hayes N. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 2005; 92: 60-7.
33. Borgen E, Naube B, Nesland J M, Kvalheim G, Beiske K, Fodstad O. Standardisation of the immunocytochemical detection of cancer cells in BM and blood: Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1999; 1: 377-88.
34. Borgen E, Beiske K, Trachsel S et al. Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 1998; 185: 427-34.